St. Jude Medical, a St. Paul, Minn.-based medical device manufacturer, said it restructured its product divisions into two operating units and named Dr. Eric Fain and Frank Callaghan as the units' leaders.
Fain is now president of the implantable-electronic systems division, which is made up of St. Jude's former cardiac rhythm management and neuro-modulation divisions, according to a news release. He previously served as president of the cardiac rhythm management division.
Callaghan will oversee the cardiovascular and ablation technologies division, which includes the former atrial fibrillation and cardiovascular divisions. He has served as president of the cardiovascular division since 2008. Ages for Fain and Callaghan were not available.
"The reorganization we have announced today is part of a comprehensive plan to accelerate our growth," said Daniel Starks, St. Jude's chairman, president and CEO, in the news release. "We are focused on reducing costs, leveraging economies of scale, maintaining the highest level of quality and funding our entire portfolio of new growth drivers."